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Abstract
Introduction: The critical care management of traumatic brain injury focuses on preventing secondary ischemic
injury. Cerebral oxygen delivery is dependent upon the cerebral perfusion pressure and the oxygen content of
blood, which is principally determined by hemoglobin. Despite its importance to the cerebral oxygen delivery, the
precise hemoglobin concentration to provide adequate oxygen delivery to injured neuronal tissue in TBI patients is
controversial with limited evidence to provide transfusion thresholds.
Methods: We conducted a retrospective cohort study of severe TBI patients, investigating the association between
mean 7-day hemoglobin concentration and hospital mortality. Demographic, physiologic, intensive care
interventions, clinical outcomes and daily hemoglobin concentrations were recorded for all patients. Patients were
all cared for at a tertiary, level 1 trauma center in a mixed medical and surgical intensive unit. Patients were
divided into quartiles based on their mean 7-day hemoglobin concentration: < 90 g/L, 90 - 99 g/L, 100 - 109 g/L
and > 110 g/L. Multivariable log-binomial regression was used to model the association between mean daily
hemoglobin concentration and hospital mortality.
Results: Two hundred seventy-three patients with traumatic brain injury were identified and 169 were included in
the analysis based on inclusion/exclusion criteria. Of these, 77% of the patients were male, with a mean age of 38
(SD 17) years and a median best GCS of 6 (IQR 5 - 7). One hundred fifteen patients (68%) received a red blood cell
(RBC) transfusion. In RBCs administered in the ICU, the median pre-transfusion hemoglobin was 79 g/L (IQR 73 -
85). Thirty-seven patients (22%) died in hospital. Multivariable analysis revealed that mean 7-day hemoglobin
concentration < 90 g/L was independently associated with an increased risk of hospital mortality (RR 3.1, 95% CI
1.5 - 6.3, p = 0.03). Other variables associated with increased mortality on multivariable regression were insertion of
external ventricular drain, age and decreased GCS. Red blood cell transfusion was not associated with mortality
following multivariable adjustment.
Conclusions: A mean 7-day hemoglobin concentration of < 90g/L is associated with increased hospital mortality
in patients with severe traumatic brain injury.
Introduction
Traumatic brain injury (TBI) affects 1.4 million indivi-
duals and accounts for greater than 50,000 deaths
annually in the US [1]. It is a major cause of mortality
and morbidity worldwide, but in recent years, advances
resulting in improved outcomes for patients with a TBI
have been made in critical care [2-5]. Despite these
advances, questions about the non-operative critical care
management of TBI, particularly transfusion practices,
remain unanswered.
Preventing secondary ischemic injury to neuronal tis-
sue by ensuring adequate cerebral oxygen delivery is a
cornerstone of post-TBI resuscitation [6-8], and the
management of anemia is paramount in this process.
Following TBI, up to 46% of patients have a hemoglobin
of less than 90 g/L during the first week of admission,
and 76% of these patients require a red blood cell (RBC)
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transfusion [9]. Transfusion of RBCs has been shown to
increase oxygen delivery and brain tissue oxygenation
[10]. However, these benefits in patients with a TBI
must be weighed against established and potentially
harmful effects of RBC transfusion [11-15].
Transfusion practices in the critically ill have been stu-
died extensively [16,17]. Currently, a hemoglobin concen-
tration of 70 g/L is an accepted transfusion trigger in an
overall population of non-bleeding critically ill patients
[16,17]. However, the clinical literature examining transfu-
sion thresholds in patients with a TBI is weak and results
are conflicting [18]. Both nadir hemoglobin [19] and ane-
mia (hemoglobin of less than 90 g/L) [9] have been asso-
ciated with increased mortality following TBI. In contrast,
a subgroup analysis of the Transfusion Requirements in
Critical Care (TRICC) trial, though underpowered, found
no difference in mortality between the restrictive (70 to
90 g/L) and the liberal (100 to 120 g/L) transfusion groups
for the TBI patients enrolled in the trial [16]. Not surpris-
ingly, no specific recommendation for optimal hemoglobin
thresholds in the Brain Trauma Foundation Guidelines
remains [6]. Although the Lund concept recommends
maintaining a hemoglobin concentration of between
125 and 140 g/L, no substantive evidence supporting this
threshold remains [20]. Given this uncertainty, we per-
formed a retrospective cohort study to determine the asso-
ciation of mean 7-day hemoglobin concentration and
mortality in patients with a severe TBI in an academic
trauma center.
Materials and methods
The Clinical Research Ethics Board at the University of
British Columbia and the Vancouver Coastal Health
Authority approved the protocol and waived the require-
ment for written informed consent.
Patient inclusion and data collection
A database of patients admitted to the intensive care unit
(ICU) at Vancouver General Hospital (VGH) between
May 2000 and March 2006 was used to construct a retro-
spective cohort of all patients with a severe TBI (Glasgow
Coma Scale (GCS) score of not more than 8). All patients
were treated in a closed, 27-bed, mixed medical-surgical
unit affiliated with the University of British Columbia.
The ICU at VGH operates on an approximate 1:1.2
nurse-to-patient ratio. Patients were excluded if they
were obeying commands within 12 hours (indicating a
non-severe TBI) or died within 12 hours of admission, as
these patients were likely to succumb irrespectively of
hemoglobin level. Patients were also excluded if they had
a non-traumatic etiology of their decreased level of
consciousness (for example, alcohol intoxication or
aneurysmal subarachnoid hemorrhage) or concomitant
traumatic quadriparesis. Data were collected by using
standardized forms and included type and severity of
injury, ICU management (including packed RBCs admi-
nistered), and neuromonitoring information. Type and
severity of injury were characterized by the following:
baseline vital signs, best GCS score within 12 hours,
mechanism and type of TBI (diffuse axonal injury, par-
enchymal contusions, extra-axial collections, or basal
skull or calvarial fractures), surgical procedures per-
formed, and features suggestive of increased intracranial
pressure (ICP) on computerized tomography scan from
radiology reports (mixed density lesion of greater than
25 mm, midline shift of greater than 5 mm, and cisternal
compression).
TBI management recorded included use of bolus manni-
tol in the emergency room (dose of 1 g/kg), therapeutic
hypothermia (target temperature and duration of therapy),
and use of neuromuscular blockers. Monitoring data
acquired included use of external ventricular drain (EVD),
ICP measurements (if EVD was present), use of jugular
venous oximetry (SjO2), SjO2 measurements, and daily
GCS score measurement. Demographic and mortality data
were obtained from the ICU database. We used all-cause
hospital mortality as our primary endpoint. In addition,
the ICU database contained the Acute Physiology and
Chronic Health Evaluation II (APACHE II) score, baseline
admission laboratory values, and vital signs for the first
24 hours. Daily morning hemoglobin levels were recorded
for each patient. The number of units of packed RBCs
administered for the first 14 days of ICU admission was
also recorded.
Traumatic brain injury management
Since 1995, VGH has used a TBI management protocol
that is based on the Brain Trauma Foundation Guidelines
[6]. All patients are maintained with the head of bed at
at least 30 degrees and their neck in a neutral position.
The mean arterial pressure is kept at at least 70 mm Hg
(ensuring adequate intravascular volume replacement
with normal saline and using norepinephrine infusion if
required), and the arterial partial pressure of oxygen
(PaO2) is kept at at least 70 mm Hg. If ICP increases
more than 20 mm Hg for more than 5 minutes without
stimulation, the EVD is opened to 26 cm H2O and cere-
brospinal fluid is drained. Opened EVDs are closed every
hour to measure ICP. If an SjO2 monitor is present, cere-
bral oxygen extraction ratio is maintained at less than
40% by ensuring adequate cerebral perfusion pressure,
sedation and paralysis (if required), and careful titration
of arterial carbon dioxide tension to modify cerebral
blood flow. Hyperthermia is avoided by using 650 mg of
acetaminophen every 4 hours and cooling blankets if
required to keep the core temperature at less than 37°C.
Cooling measures that are more aggressive may be insti-
tuted on an individual basis to maintain an ICP of less
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than 20 mm Hg if the above maneuvers are insufficient.
Patients are managed by fellowship-trained intensivists
with backgrounds in anesthesiology, emergency medi-
cine, internal medicine, or trauma surgery. Resident and
fellow house staff is in attendance 24 hours a day.
Statistical analysis
We used Stata 10.0 (StataCorp LP, College Station, TX,
USA) to analyze our data. We described categorical data,
normally distributed data, and non-normally distributed
data by using proportion (percentage; 95% confidence
interval, or CI), mean (standard deviation, or SD), and
median (interquartile range, or IQR), respectively. We
divided patients into bins on the basis of their mean 7-day
hemoglobin concentrations: less than 90 g/L, 90 to 99 g/L,
100 to 109 g/L, and at least 110 g/L. These categories
were inserted into the final model as indicator variables,
and the range of 90 to 99 g/L was used as the referent
category. Mean 7-day hemoglobin was chosen as the expo-
sure variable since the majority of patients have reached
their peak ICP by day 7 [21]. We used multivariable log-
binomial regression to model the association between
mean 7-day hemoglobin concentration and hospital mor-
tality. Fractional polynomials were used to ensure the best
functional form of the continuous variables of ‘age’ and
‘GCS’. Covariates included in the final outcome model
were chosen a priori and included the age of the patient,
admission GCS score, insertion of EVD, and any RBC
transfusion received. A complete-case analysis was per-
formed, and a P value of less than 0.05 was considered
statistically significant.
Results
In total, 273 patients with a TBI were screened for this
study. One hundred four met our exclusion criteria, and
169 were included in the analysis (Figure 1). No data
were missing. Patients were divided into bins on the
basis of daily mean hemoglobin concentrations, and
baseline characteristics are listed in Table 1. The major-
ity of patients were male (77%), the mean age was
38 (SD 17) years, and the median best GCS score within
12 hours was 6 (IQR 5 to 7).
Clinical interventions and outcomes for the cohort are
presented in Table 2. There was no difference in utiliza-
tion of neurological monitoring (EVD or jugular bulb) or
application of therapeutic hypothermia between levels of
mean hemoglobin concentration. Overall, the median
duration of intensive care was 9 (IQR 4 to 18) days, and
mechanical ventilation was required for 7 (IQR 4 to 17)
days. There was no difference in duration of mechanical
ventilation or intensive care between groups. There were
no differences in the radiographic features of TBI from
computed tomography or treatment interventions among
the quartiles. However, there were higher 28-day and
hospital mortality rates in patients with a mean 7-day
hemoglobin concentration of less than 90 g/L.
In total, 575 units of RBCs were transfused in 115 (68%)
of 169 patients. Transfused patients received a median of
8 (IQR 5 to 12) units of RBCs. The median number of sto-
rage days of the RBCs was 19 (IQR 13 to 29). Two
hundred seventy-seven transfusions were given in either
the emergency department or operating room prior to
admission to the ICU. The remaining 298 transfusions
were given during the ICU stay. Pre-transfusion hemoglo-
bin concentrations were available for packed RBCs admi-
nistered in the ICU. Frequency distribution of pre-
transfusion hemoglobin concentration is presented in
Figure 2. Thirty-five (12%) and 131 (44%) were adminis-
tered for hemoglobin concentrations of less than 70 g/L
and between 70 and 79 g/L, respectively. Only 4 (1%)
transfusions were administered for a hemoglobin concen-
tration of at least 100 g/L. The median pre-transfusion
hemoglobin was 79 g/L (IQR 73 to 85).
Log-binomial regression modeling the association
between the mean 7-day hemoglobin and hospital mortal-
ity is presented in Table 3. Univariate analysis demon-
strated that a mean 7-day hemoglobin of less than 90 g/L
was associated with an increased risk of hospital mortality.
This result persisted after multivariable adjustment (risk
ratio (RR) 3.1, 95% CI 1.5 to 6.3, P = 0.002). On multivari-
able analysis, insertion of EVD, age, and lower admission
GCS score were also associated with increased mortality.
Although RBC transfusion was associated with increased
hospital mortality on univariate analysis (RR 2.4, 95% CI
1.1 to 5.5, P = 0.03), this result did not persist in the final
multivariable analysis.
Discussion
In this retrospective cohort study of 169 patients
admitted to the ICU after a severe TBI, multivariate
analysis demonstrated that mean 7-day hemoglobin
Figure 1 Total patients screened and then included in the final
analysis. Reasons for exclusion are shown. CNS, central nervous
system; TBI, traumatic brain injury.
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concentrations of less than 90 g/L were independently
associated with a threefold increase in hospital mortality.
Furthermore, clinicians appeared to maintain a transfu-
sion threshold of between 70 and 90 g/L.
Anemia results in a normal physiological response to
increase cardiac output and therefore cerebral blood flow.
In TBI, cerebral autoregulation may be impaired and
increased cerebral blood flow with anemia may result in
cerebral hyperemia, which exacerbates cerebral edema and
neuronal damage in TBI. Animal models of TBI have
shown that normovolemic anemia results in decreased
brain tissue oxygenation in comparison with a TBI without
anemia [22]. Furthermore, anemia exacerbates secondary
injury among rats with a TBI by enlarging cerebral contu-
sional areas and enhancing apoptosis [22]. In humans with
a TBI, transfusion of RBCs increases brain tissue oxygen
[10,23]. Zygun and colleagues [23] demonstrated this
improvement in brain tissue oxygenation; however,
transfusion of RBCs did not into improvement in cerebral
microdialysis markers of metabolism. However, microdialy-
sis samples only a fraction of the injured brain, and it may
also be that these patients were not in an oxygen delivery-
dependent state [24]. Despite this beneficial physiological
effect on cerebral oxygen delivery, transfusion in critically
ill patients has been associated with many detrimental
effects, including increased risk of nosocomial infections
[13], prolonged hospital and ICU stays, and increased mor-
tality [17]. Given these complex interactions, it is not sur-
prising that the evidence examining the relationship
between anemia and clinical outcomes is conflicting
[18,25,26].
Several observational studies present often contradic-
tory results, even within the same study. In a retrospec-
tive cohort study of patients with a severe TBI, Carlson
and colleagues [19] demonstrated that transfusion and
lowest measured hematocrit were associated with worse
Table 1 Baseline characteristics of patients by mean 7-day hemoglobin concentration
Characteristic Hemoglobin P value
<90 g/L







Age in years, mean (SD) 39 (19) 37 (18) 36 (18) 40 (15) 0.83
Male gender, number (percentage) 17 (68) 48 (80) 38 (83) 28 (76) 0.55
APACHE II score, mean (SD) 26 (5) 23 (4) 24 (5) 22 (4) 0.56
SBP <90 mm Hg, number (percentage) 6 (24) 10 (16) 9 (20) 7 (19) 0.87
PaO2 <70 mm Hg, number (percentage) 3 (12) 7 (11) 3 (7) 2 (5) 0.65
GCS score in 12 hours, median (IQR) 6 (5-7) 6 (6-7) 6 (5-7) 6 (6-7) 0.56
Mannitol, number (percentage) 9 (36) 31 (51) 26 (57) 19 (51) 0.14
CT of head, number (percentage)
Traumatic subarachnoid hemorrhage 17 (68) 31 (51) 21 (46) 21 (57) 0.32
Diffuse axonal injury 12 (48) 21 (34) 9 (20) 9 (24) 0.07
Subdural hematoma 11 (44) 24 (39) 17 (37) 14 (38) 0.95
Features of increased ICP 10 (40) 31 (51) 26 (57) 20 (54) 0.60
Basal skull fracture 3 (12) 19 (31) 12 (27) 8 (22) 0.29
Craniotomy performed, number (percentage) 8 (32) 19 (31) 23 (50) 15 (41) 0.22
APACHE II, Acute Physiology and Chronic Health Evaluation II; CT, computed tomography, GCS, Glasgow Coma Scale; ICP, intracranial pressure; PaO2, arterial
partial pressure of oxygen; SBP, systolic blood pressure; SD, standard deviation.
Table 2 Clinical interventions and outcomes in all patient quartiles









Therapeutic hypothermia <35°C, number (percentage) 7 (28) 8 (13) 10 (22) 7 (19) 0.38
Therapeutic hypothermia <38°C, number (percentage) 7 (28) 22 (36) 16 (35) 12 (32) 0.92
EVD inserted, number (percentage) 14 (56) 31 (51) 29(63) 23 (62) 0.57
Jugular bulb inserted, number (percentage) 10 (40) 27 (44) 26 (56) 16 (43) 0.47
Days of EVD, median (IQR) 10 (6-16) 7 (5-12) 8 (6-12) 8 (4-12) 0.47
Days of mechanical ventilation, median (IQR) 9 (5-18) 9 (6-12) 7 (4-12) 5 (4-10) 0.29
ICU days, median (IQR) 9 (6-20) 12 (7-15) 9 (5-14) 8 (5-10) 0.44
28-day mortality, number (percentage) 10 (40) 8 (13) 9 (20) 4 (11) 0.03
Hospital mortality, number (percentage) 12 (48) 8 (13) 11 (24) 6 (16) 0.006
EVD, external ventricular drain; ICU, intensive care unit; IQR, interquartile range.
Sekhon et al. Critical Care 2012, 16:R128
http://ccforum.com/content/16/4/R128
Page 4 of 7
outcomes at discharge. Paradoxically, within that same
study, number of days with a hematocrit of less than 30%
was associated with improved outcomes as measured by
GCS score and Glasgow Outcome Score (GOS). How-
ever, that analysis has many methodologic concerns -
including the possibility of covariate colinearity [27],
model overfitting, and misspecification - which limit the
interpretability of the results. Salim and colleagues [9], in
a retrospective cohort study of 1,150 TBI patients
admitted to the ICU, demonstrated that transfusion, but
not anemia (hemoglobin of less than 90 g/L), was asso-
ciated with higher mortality. The authors did test for
effect measure modification of anemia and transfusion by
inserting an interaction term in the final model, which
was not significant. Warner and colleagues [26] pre-
sented worse long-term functional outcomes by using the
extended GOS on a linear scale with transfusion as both
a linear and dichotomous variable. In a subgroup analysis
of patients with a severe TBI in the TRICC trial by McIn-
tyre and colleagues [28], the restrictive (hemoglobin of 70
to 90 g/L) and liberal (hemoglobin of 100 to 120 g/L)
transfusion strategies did not differ in 30-day mortality
or length of stay. However, this substudy was underpow-
ered; only 67 patients were included between the two
groups. Interestingly, a recent retrospective study by
Oddo and colleagues [29] demonstrated that a hemoglo-
bin of less than 90 g/L was associated with brain tissue
oxygenation (PbtO2) of less than 20 mm Hg and an unfa-
vorable outcome, which correlates with our finding that a
mean 7-day hemoglobin concentration of less than 90 g/L
is independently associated with a threefold increase in
hospital mortality.
An interesting finding is the pre-transfusion hemoglo-
bin levels in our study. The CRIT study, a multicenter
observational cohort study of ICU patients in the US,
demonstrated a mean pre-transfusion hemoglobin level
of 86 g/L (SD 17), which was remarkably constant across
varying types of ICUs [17]. Sena and colleagues [30]
recently conducted a survey of trauma surgeons, neuro-
surgeons, and non-surgeon critical care physicians at
level 1 trauma centers in the US to compare transfusion
practices in patients with an acute severe TBI. In scenar-
ios involving patients with normal ICPs, neurosurgeons
Figure 2 Frequency of transfusions in each patient group according to pre-transfusion hemoglobin concentration.
Table 3 Log-binomial regression modeling the
association between mean 7-day hemoglobin and
hospital mortality
Variable RRunadj RRadj 95% CI P value
Hemoglobin range
<90 g/L 3.7 3.1 1.5-6.3 0.002
90-99 g/L - - - -
100-110 g/L 1.8 1.5 0.70-3.2 0.29
>110 g/L 1.2 1.2 0.49-2.7 0.75
Insertion of EVD 2.3 2.7 1.5-5.1 0.001
Age in years 1.0 1.0 1.0-1.1 <0.001
Transfusion of RBCs 2.4 1.4 0.64-2.9 0.42
Admission GCS score 0.81 0.85 0.74-0.99 0.04
CI, confidence interval; EVD, external ventricular drain; GCS, Glasgow Coma
Scale; RBC, red blood cell; RRadj, adjusted risk ratio; RRunadj, unadjusted risk
ratio.
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preferred a higher transfusion threshold (83 g/L, SD 12)
in comparison with trauma surgeons (75 g/L, SD 10) and
non-surgeon intensivists (75 g/L, SD 8). In scenarios with
elevated ICP, transfusion thresholds increased in all three
groups, but the difference between neurosurgeons and
the trauma surgeons and intensivists persisted (89 g/L,
SD 11; 80 g/L, SD 11; and 84 g/L, SD 11, respectively)
[30]. In our study, the median pre-transfusion hemoglo-
bin of 79 g/L was consistent with transfusion thresholds
of the trauma surgeons and non-intensivists in the survey
by Sena and colleagues. Interestingly, our closed mixed
medical-surgical ICU is staffed by fellowship-trained cri-
tical care physicians from varying subspecialty back-
grounds (four anesthesiologists, two emergency medicine
physicians, four internal medicine physicians, and one
trauma surgeon) but does not include a neurosurgeon
intensivist. However, the comparison of our results with
the study by Sena and colleagues should be interpreted
with caution as the latter represents survey data rather
than actual transfusion thresholds from a clinical study.
A major limitation of all available clinical studies, ours
included, is the inadequate consideration of transfusion
in the analysis. Appropriate adjustment for transfusion
may help reduce bias between anemia and outcome but
may hide an important relationship across subgroups.
For example, patients with the same hemoglobin concen-
tration of 90 g/L may have very different outcomes,
depending on whether they receive an RBC transfusion
or not. Thus, rather than statistical adjustment of trans-
fusion, it may be more informative to look for effect mea-
sure modification between hemoglobin levels and RBC
transfusion. Because of our small sample size, we were
unable to test for these important subgroup effects.
Furthermore, we considered transfusion a time-insenstive
dichotomous variable in only the final multivariable
model, which fails to account for the important interac-
tion between time, transfusion, and hemoglobin concen-
tration. Additional limitations of our study need to be
addressed. By using indicator variables that allow a non-
linear relationship of hemoglobin concentration to
mortality in our model, we have tried to avoid model
misspecification. It is possible that residual confounding
may occur within strata of hemoglobin concentrations.
More importantly, it is unclear how best to measure
‘exposure’ to hemoglobin levels. A priori, we chose mean
7-day hemoglobin concentration because the majority of
patients have achieved their peak ICP by that time per-
iod. Other observational studies have used a variety of
similar approaches, including number of days with a
hematocrit of less than 30% and lowest mean hematocrit
[19], a hemoglobin of less than 90 g/L for three consecu-
tive measurements [9], and lowest hematocrit level [31].
All of these approaches have limitations that may result
in exposure misclassification. In addition, the decision to
transfuse would be subject to strong confounding by
indication [32]. Thus, even with regression adjustment
for transfusion, there would be residual or unmeasured
confounding, which remains an alternative explanation
for our results. In keeping with many of the aforemen-
tioned studies on TBI, we do not have outcome data on
functional status, which is arguably more important in
this population. These important limitations notwith-
standing, this study should be used to guide further
hypotheses and study designs to more formally assess the
relationship between anemia, transfusion, and outcomes
in patients with a TBI.
Conclusions
We have demonstrated that a mean 7-day hemoglobin
concentration of less than 90 g/L may be harmful in
patients with a severe TBI. Large well-controlled obser-
vational studies that are powered to examine important
subgroup effects (for example, RBC transfusion by
hemoglobin concentration) and time-varying covariates
(for example, ICP) are warranted to characterize both
hemoglobin concentrations and transfusion thresholds
to guide clinicians managing patients with a TBI.
Key messages
• Definitive data on transfusion thresholds and anemia
management in TBI are lacking.
• A hemoglobin level of less than 90 g/L is associated
with a threefold increase in hospital mortality.
• Large and well-designed multicenter observational
studies and randomized control trials are needed to
further elucidate transfusion thresholds for anemia in
patients with a TBI.
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